Atlas Trials

Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies

Clinical trial NCT02164071 · COMPLETED

Trial details

NCT number
NCT02164071
Sponsor
Celgene
Status
COMPLETED
Study type
OBSERVATIONAL
Myelodysplastic SyndromesLeukemia Myeloid AcuteMultiple MyelomaLeuklemia, Lymphocytic, Chronic
Start date
2012-04-11
Primary completion
2013-12-03
Enrollment
363

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.